Cite
HARVARD Citation
Goldstein, N. et al. (2022). Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study. Journal of infectious diseases. pp. 595-607. [Online].